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Abstract
Background: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease and one of the most common indications for 
cholangiography (ERCP). We undertook this study to clarify whether there is a specific pattern of involvement of the biliary tract in 
patients with PSC and to evaluate features of PSC disease on ERCP in order to be able to manage this disease better.
Methods: This retrospective study included 45 patients admitted to Taleghani Hospital in 2004–2010 and diagnosed to have PSC on 
the basis of typical cholangiographic findings in combination with clinical and laboratory data. Patients suspected to have secondary 
sclerosing cholangitis were excluded. Demographic and clinical data were recorded, along with cholangiographic findings and the 
 frequency of large duct and small duct PSC.
Results: Forty-five patients of mean age 34.8 (range 15–66) years were included. Twenty-nine patients (64.4%) had inflammatory 
bowel disease, and the frequency of large duct PSC and small duct PSC was 93.4% and 6.6%, respectively. The intrahepatic ducts alone 
were involved in 11 (24.4%) patients and the extrahepatic ducts were involved in 14 (31.1%), with 17 (37.7%) patients having both 
intrahepatic and extrahepatic PSC. Three (6.6%) patients did not have bile duct involvement on ERCP, and their disease was diagnosed 
by liver biopsy as small duct PSC. The most common type of cholangiographic feature of intrahepatic duct involvement was type 2, 
found in 15 (33.3%) patients, with type 3 being the most common type of extrahepatic duct involvement and detected in 16 (35.5%) 
patients.
Conclusion: Our study demonstrates that the most common PSC finding on ERCP is involvement of both the extrahepatic and intrahe-
patic bile ducts, with small duct PSC being less common than large duct PSC.
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liver transplantation in adults. There are conflicting data regarding characteristic findings of PSC disease on endoscopic retrograde 
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Introduction
Primary sclerosing cholangitis (PSC) is a chronic 
cholestatic liver disease and one of the most common 
indications for liver transplantation in adults. PSC is 
characterized by recurrent fever, pain, and jaundice, 
resulting from fibrosing and inflammatory obstruc-
tion of the bile ducts.1–3 Diagnosis of PSC is based 
on typical cholangiographic findings in the setting of 
consistent clinical, biochemical, serologic, and his-
tologic findings, after exclusion of secondary causes 
of sclerosing cholangitis. Endoscopic retrograde cho-
langiography (ERCP) is considered the gold standard 
for establishing a diagnosis of PSC and provides a 
method for tissue sampling that is unavailable with 
other imaging modalities, and additionally provides a 
means for palliative measures.4,5
Both the extrahepatic and intrahepatic bile ducts 
are abnormal in approximately 75% of patients. The 
intrahepatic ducts alone are involved in 15%–20% of 
cases.6–9 Abnormalities of the extrahepatic biliary tree 
in the absence of intrahepatic involvement are less 
common.10,11 The cystic duct and gallbladder may be 
involved in up to 15% of cases, but may not be visu-
alized well on routine cholangiography.12 Pancreatic 
duct irregularities similar to those seen in chronic 
pancreatitis may occasionally be noted.13,14
The frequency of diagnosis of PSC has increased 
dramatically in the last 20 years. This increase likely 
reflects increased clinical awareness and use of ERCP. 
We conducted this study to investigate the frequency 
of large duct and small duct PSC and the characteristic 
hepatic and extrahepatic bile duct findings on ERCP.2
Methods
In this retrospective study, we identified 221 patients 
who were admitted to the Department of Gastroenter-
ology at Taleghani Hospital in 2004–2010 with a diag-
nosis of sclerosing cholangitis. Of these, 45 patients 
were diagnosed to have PSC by a gastroenterologist 
experienced in ERCP, based on typical cholangio-
graphic findings in combination with clinical and 
laboratory data with or without magnetic resonance 
cholangiopancreatography and liver biopsy. Patients 
with suspected secondary causes of sclerosing cholan-
gitis due to choledocholithiasis, cholangiocarcinoma, 
lymphoma, pyogenic cholangitis, chronic pancreatitis, 
congenital abnormalities, or  primary  biliary cirrhosis 
were excluded. Demographic and clinical informa-
tion, all cholangiographic findings, and the frequency 
of large duct and small duct PSC were recorded. Cho-
langiographic findings were reviewed retrospectively. 
The severity of bile duct strictures was scored using 
a classification system validated for PSC patients15 
(Table 1). Ethical approval was obtained for the use 
of human subjects in this research.
Results
A total of 45 patients were included. Mean age was 
34.8 (range 15–66) years. Fifteen patients (33.3%) 
were female and 30 (66.6%) were male. Twenty-
nine (64.4%) patients had inflammatory bowel dis-
ease, 57.7% as a result of ulcerative colitis and 6.6% 
because of Crohn’s disease. Forty-three patients were 
nonsmokers, and cirrhosis was detected in eight 
(17.8%) patients and gallstones in 13 (28.9%). Nine 
(20%) patients had undergone partial colectomy and 
two (4.4%) p had had total colectomy.
Among these patients, 46.7% had pruritus and 
55.6% had jaundice. In one patient with inflammatory 
bowel disease, PSC was diagnosed before the onset 
of inflammatory bowel disease. Demographic charac-
teristics and laboratory values are shown in Table 2.
The frequency of large duct PSC was 93.4%. The 
intrahepatic ducts alone were involved in 11 (24.4%) 
patients and the extrahepatic ducts were involved in 14 
(31.1%), with 17 (37.7%) patients having both intrahe-
patic and extrahepatic PSC. Three (6.6%) patients did 
not have bile duct involvement on ERCP and their dis-
ease was diagnosed by liver biopsy as small duct PSC.
Table 1. Ductal scoring system.
Intrahepatic ducts (10 mm proximal from hilum)
0 no visible abnormalities
1  Multiple strictures, normal caliber of bile ducts or 
minimal dilatation
2  Multiple strictures, saccular dilatations, decreased 
arborization
3 Only central branches seen, diffuse severe pruning
extrahepatic ducts
0 no visible abnormalities
1 Slight irregularities of duct contour, no stricture
2 Segmental strictures
3 Stricture of almost entire length of duct
4  extremely irregular margin, diverticulum-like 
outpouchings
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PSC disease seen on erCP
The most common type of cholangiographic fea-
ture of intrahepatic duct involvement was type 2 in 
15 (33.3%) patients, and type 3 was the most com-
mon type of extrahepatic duct involvement detected 
in 16 (35.5%) patients. Characteristic ERCP findings 
for bile duct strictures are shown in Table 3.
Discussion
PSC is often seen in association with inflammatory 
bowel disease, and visualization of the biliary tract 
is essential for confirmation of a diagnosis of PSC. 
Increased physician awareness and accessibility of 
ERCP allow earlier recognition of the disease in the 
asymptomatic stage.2,16
In most cases of PSC, multifocal bile duct strictures 
alternating with normal caliber bile ducts or dilated bile 
duct segments are found throughout the intrahepatic 
and extrahepatic biliary tree and are responsible for the 
beaded cholangiographic appearance characteristic of 
the disease.17 The strictured segments are usually short, 
annular, or band-like in appearance, although longer 
confluent strictures may be seen in more advanced 
disease. In addition, Craig et al found that type and 
location of bile duct involvement can be a prognostic 
factor because high-grade intrahepatic bile duct stric-
tures (greater than 75% narrowing) and diffuse intrahe-
patic strictures are associated with a 19% decrease in 
three-year survival.18 Kaplan et al reported 0.92 cases 
per 100,000 and 0.15 cases per 100,000 person-years 
for an annual incidence of large duct PSC and small 
duct PSC, respectively, indicating that small duct PSC 
is less common than large duct PSC.19
In our study, the frequency of large duct PSC and 
small duct PSC was 93.4% and 6.6%, respectively. 
In the literature, both extrahepatic and intrahepatic 
bile duct involvement is reported in approximately 
75% of cases, with intrahepatic duct involvement 
alone in 15%–20% of cases.6–9  Abnormalities of the 
extrahepatic biliary tree in the absence of intrahe-
patic involvement are reported to be less common,9,10 
which is concordant with our findings. However, 
37.7% of our cases had both intrahepatic and extra-
hepatic duct involvement, which is less than reported 
elsewhere.
The literature also suggests that the extrahe-
patic ducts are normal and the changes are con-
fined to the intrahepatic and proximal extrahepatic 
ducts in about 20% of cases, but we detected a 
24% frequency of intrahepatic biliary involve-
ment and a 31.1%  frequency of extrahepatic biliary 
tree  abnormalities.20 However, there was a relative 
small number of patients in our study and we did 
not include an appropriate control group, so further 
studies with larger sample sizes and appropriate 
controls are required.
conclusion
Our study demonstrates that the most common ERCP 
finding for PSC is involvement of both the extrahe-
patic and intrahepatic bile ducts, with small duct PSC 
being less common than large duct PSC.
Table 2. Characteristic findings of primary sclerosing 
cholangitis.
characteristics patients (n = 45)
Mean age, years 34.8
Female 
Male
15 (33.3%) 
30 (66.6%)
IBD 
UC 
CD
29 (64.4%) 
26 (57.7%) 
3 (6.66%)
Clinical findings 
 Jaundice 
 Pruritus
 
25 (55.6%) 
21 (46.7%)
Laboratory findings 
hb (g/dL) 
WBC (mm3) 
PLT (×109/L) 
ALT (U/L) 
AST (U/L) 
ALP (U/L) 
TBil (mg/dL) 
DBil (mg/dL) 
Albumin (g/dL)
Mean 
10.7 
10,600 
194,000 
90.53 
94.44 
1199 
6.3 
3.6 
3.5
Abbreviations: CD, Crohn’s disease; IBD, inflammatory bowel disease; 
UC, ulcerative colitis; WBC, white blood cells; hb; hemoglobin; ALT, 
alanine transaminase; AST, aspartate transaminase; ALP, alkaline 
phosphatase.
Table 3. Characteristic endoscopic retrograde cholangiog-
raphy bile duct stricture findings.
extrahepatic psc Intrahepatic psc
Type 0 (6.6%) Type 0 (6.6%)
Type 1 (0%) Type 1 (22.2%)
Type 2 (22.2%) Type 2 (33.3%)
Type 3 (35.5%) Type 3 (6.6%)
Type 4 (11.1%)
Abbreviation: PSC, primary sclerosing cholangitis.
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